82 episodes
Cell & Gene: The Podcast Erin Harris
-
- Science
-
-
4.9 • 36 Ratings
-
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
-
Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington
We love to hear from our listeners. Send us a message.Lucas Harrington, Co-Founder and Chief Scientific Officer of Mammoth Biosciences, joins Erin Harris to shed light on the biotech's proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for patients with life-threatening and debilitating diseases. They discuss why in vivo delivery continues to be a bottleneck against the clinical advancement of gene-editing-based medicines and what ultracompact CRISPR sys...
-
TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.
We love to hear from our listeners. Send us a message.KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Erin Harris to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the SOCS1 gene is inactivated by CRISPR/Cas9 gene editing. In addition to solid tumors, Benson also addresses the therapeutic potential for autoimmune di...
-
Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft
We love to hear from our listeners. Send us a message.Strand Therapeutics' CEO and Co-Founder Jake Becraft joins Erin Harris to discuss genetic regulation and how the company's programmable mRNA constructs combine genes for self-replication derived from RNA viruses with genetically programmed logic circuits that control the location, timing, and intensity of expression of therapeutic proteins within the patient’s body, enabling precise and controlled delivery. They also cover the role synthet...
-
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
We love to hear from our listeners. Send us a message.Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
-
The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley
We love to hear from our listeners. Send us a message.Dr. Bambi Grilley is Professor of Pediatrics and the Director of Clinical Research and Early Product Development for the Center of Cell and Gene Therapy (CAGT) at Baylor College of Medicine AND she is Chief Regulatory Officer at ISCT. Dr. Grilley talks to us about her role as CRO at ISCT and the global regulatory landscape for cell and gene therapies. She takes a deep dive into the pediatric patient journey, and she shares her expectations...
-
Dr. Bruce Levine on ISCT and the Future of CAR-T
We love to hear from our listeners. Send us a message.In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more. He talks about his time and learnings as President Elect, President, and Immediate Past President of ISCT. He covers Cellicon Valley and Philadelphia's success as on-going CGT hub, and much more.
Customer Reviews
Top Notch Podcast
I’ve learned a great deal listening to this podcast. Erin Harris does a fantastic job of keeping the topics current and the guests she has on are all leaders in the industry.
Must listen for anyone in this market
If you’re interested in what the leaders of the cell therapy and gene therapy market think, this is well worth a subscribe.
Required Listening
The cell and gene space is growing and developing quickly. The Cell and Gene Podcast is the best way to keep up with this exciting and quickly developing segment of the pharma industry.